|
|
 |
|
Viewing report
|
|
|
|
European External Defibrillators Market
Frost & Sullivan, Aug 2007
This Frost & Sullivan research titled European External Defibrillator Market provides a comprehensive analysis of the market. The study highlights the main drivers, restraints and geographic trends influencing the market. Moreover, it includes detailed profiles of 6 key participants in the external defibrillator market in Europe. Finally, revenue forecasts, market share analysis and strategic recommendations to participants are provided. In this research, Frost & Sullivan’s expert analysts thoroughly examine the automatic external defibrillators and manual external defibrillators segments.
Market Sectors
Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:
-Automatic external defibrillators
-Manual external defibrillators
Market Overview
Spiralling Public Awareness and Technological Advances Propel Growth in the European External Defibrillator Market
Increasing awareness regarding sudden cardiac arrests and the need for prompt defibrillation are resulting in modest, yet steady growth rates in the European external defibrillators market. Apart from the rise in public awareness, governmental participation has resulted in a booming market for external defibrillators.
'The increase in the ageing population and the surge in the number of sudden cardiac arrests are the main factors driving the use of external defibrillators in Europe,' notes the analyst of this research service. 'Moreover, external defibrillators will experience tremendous growth in the commercial and the public access market.'
Market Participants to Focus on Strategic Alliances to Combat Intensifying Competition
Public access defibrillation (PAD) and first-responder programmes are now widespread in Europe. While the PAD market penetration is pegged at a mere 20 per cent, it is expected to grow significantly in the future. Moreover, technology continues to play an important role in the market and is increasingly being used to overcome clinical challenges such as staffing shortages and steadily improve treatment along with patient monitoring capabilities.
However, the market is faced with challenges such as stringent laws that restrict the use of defibrillation, resulting in fierce competition. Despite the dominance of three strong Tier I participants, there is still a significant level of competition among the smaller participants. These participants would do well to form alliances with companies that can help them increase sales and subsequently their market share.
|
|
|
|
